Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus

Annals of Oncology

Volumn 18, Issue SUPPL. 6, 2007, Pages

  Agnese, V ^a   Cabibi, D ^a   Calcara, D ^a   Terrasi, M ^a   Pantuso, G ^a   Fiorentino, E ^a   Intrivici, C ^a   Colucci, G ^b   Aragona, F ^a   Gebbia, N ^a   Bazan, V ^a   Russo, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Aurora A overexpression; Barrett's oesophagus; Cell cycle; Columnar lined oesophagus; p53 protein

Indexed keywords

AURORA A KINASE; MESSENGER RNA; PROTEIN P53; AURORA KINASE; BIOLOGICAL MARKER; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ADULT; BARRETT ESOPHAGUS; CANCER GROWTH; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; ESOPHAGUS TUMOR; EVALUATION; GENETICS; METABOLISM; MIDDLE AGED; MUCOSA; PATHOLOGY;

ADENOCARCINOMA; ADULT; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES;

EID: 35748958133     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm237     Document Type: Conference Paper

References (44)

1. Spechler SJ, Robbins AH, Rubins HB et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87(4): 927-933.
2. Jankowski JA, Wright NA, Meltzer SJ et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154(4): 965-973.
3. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagits'. Br J Surg 1950; 38(150): 175-182.
4. Lortat-Jacob JL. L'endobrachy-oesophage. Ann Chir 1957; 11: 1247-1254.
5. Levine DS, Rubin CE, Reid BJ, Haggitt RC. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest 1989; 60(3): 418-432.
6. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895.
7. Takubo K, Vieth M, Aryal G et al. Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: A pathognomonic feature of Barrett's esophagus? Hum Pathol 2005; 36(3): 269-274.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5): 759-767.
9. McManus DT, Olaru A, Meltzer SJ. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 2004; 64(5): 1561-1569.
10. Casson AG, Mukhopadhyay T, Cleary KR et al. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991; 51: 4495-4499.
11. Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: A follow-up study. Gastroenterology 1993; 105: 1637-1642.
12. Hamelin R, Flejou JF, Muzeau F et al. TP53 mutations, and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus. Gastroenterology 1994; 107: 1012-1018.
13. Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001; 13(3): 332-337.
14. Brown JP, Pagano M. Mechanism of p53 degradation. Biochim Biophys Acta 1997; 1332(2): 1-6.
15. Takashi T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 2000; 33: 1-6.
16. Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001; 13(3): 332-337.
17. Younes M, Lechago J, Chakraborty S et al. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia. Scand J Gastroenterol 2000; 35(2): 131-137.
18. Dutertre S, Descamps S, Prigent C. On the role of aurora-A in centrosome functon. Oncogene 2002; 21(40): 6175-6183.
19. Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004; 14: 29-36.
20. Tanaka T, Kimura M, Matsunaga K et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999; 59: 2041-2044.
21. Sakakura C, Hagiwara A, Yasuoka R et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001; 84: 824-831.
22. Bischoff JR, Anderson L, Zhu Y et al. A homologue of Drosophila Aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17: 3052-3065.
23. Sen S, Zhou H, Zhang RD et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002; 94: 1320-1329.
24. Zhu J, Abbruzzese JL, Izzo J et al. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet Cytogenet 2005; 159: 10-17.
25. Gritsko TM, Coppola D, Paciga JE et al. Activation and overexpression of centrosome kinase BTAK/Aurora A, in human ovarian cancer. Clin Cancer Res 2003; 9: 1420-1426.
26. Pihan GA, Purohit A, Wallace J et al. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 2212-2219.
27. Tanaka E, Hashimoto Y, Ito T et al. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005; 11(5): 1827-1834.
28. Haruki N, Harano T, Masuda A et al. Persistent increase in chromosome instability in lung cancer: Possible indirect involvement of p53 inactivation. Am J Pathol 2001; 159: 1345-1352.
29. Liu Q, Kaneko S, Yang L et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 2004; 279: 52175-52182.
30. Bian YS, Osterheld MC, Bosman FT et al. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001; 14: 397-403.
31. Skacel M, Petras RE, Rybicki LA et al. p53 expression in low grade dysplasia in Barrett's esophagus: Correlation with interobserver agreement and disease progression. Am J Gastroenterol 2002; 97(10): 2508-2513.
32. Weston AP, Banerjee SK, Sharma P et al. p53 protein overexpression in low-grade dysplasia (LGD) in Barrett's esophagus. Immunohistochemical marker predictive of progression. Am J Gastroenterol 2001; 96: 1355-1362.
33. Batts KP. Barrett esophagus-more steps forward. Hum Pathol 2001; 32: 357-359.
34. Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of poles. Nat Rev Cancer 2005; 5: 42-50.
35. Gritsko TM et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003; 9: 1420-1426.
36. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 2065-2071.
37. Miyoshi Y, Iwao K, Egawa C, Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 2001; 92: 370-373.
38. Tong T, Zhong Y, Kong J et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10(21): 7304-7310.
39. Chaves P, Cardoso P, de Almeida JC et al. Non-goblet cell population of Barrett's esophagus: An immunohistochemical demonstration of intestinal differentiation. Hum Pathol 1999; 30(11): 1291-1295.
40. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology 2005; 46(4): 361-373.
41. Lombard C. Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology 2006; 49(1): 97-98.
42. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology 2006; 49(1): 97-98.
43. Goldblum JR, Lee RG. Esophagus. In Stenberg (ed): Diagnostic Surgical Pathology. Philadelphia, PA: Lippincott Williams & Wilkins 2004.
44. Coad RA, Shepherd NA. Barrett's oesophagus: Definition, diagnosis and pathogenesis. Curr Diagn Pathol 2003; 9(4): 218-227.